Home » Stocks » INSP

Inspire Medical Systems, Inc. (INSP)

Stock Price: $194.60 USD 3.00 (1.57%)
Updated May 7, 2021 4:00 PM EDT - Market closed
Market Cap 5.30B
Revenue (ttm) 134.39M
Net Income (ttm) -57.17M
Shares Out 27.14M
EPS (ttm) -2.13
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day May 7
Last Price $194.60
Previous Close $191.60
Change ($) 3.00
Change (%) 1.57%
Day's Open 194.05
Day's Range 192.37 - 199.68
Day's Volume 266,491
52-Week Range 65.71 - 252.25

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Inspire (INSP) delivered earnings and revenue surprises of 7.69% and 9.18%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

5 days ago - Zacks Investment Research

MINNEAPOLIS, May 04, 2021 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and mini...

5 days ago - GlobeNewsWire

MINNEAPOLIS, April 28, 2021 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and mi...

1 week ago - GlobeNewsWire

Reimbursement Review of Inspire Therapy Completed by Japan Ministry of Health Labour and Welfare (MHLW); National Health Insurance Payment Listing Expected in June 2021

1 week ago - GlobeNewsWire

Three stocks to have on your radar in the healthcare space.

Other stocks mentioned: RMD, VVOS
1 month ago - The Motley Fool

MINNEAPOLIS, March 31, 2021 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) ("Inspire"), a medical technology company focused on the development and commercialization of innovative and mi...

1 month ago - GlobeNewsWire

Two-incision approach reduces average procedure time by approximately 20 percent Two-incision approach reduces average procedure time by approximately 20 percent

1 month ago - GlobeNewsWire

Inspire (INSP) delivered earnings and revenue surprises of 37.78% and 10.18%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

Shares of Inspire Medical Systems (NYSE:INSP) rose in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share were up 26.32% over the past year to ($0.28), which...

2 months ago - Benzinga

MINNEAPOLIS, Feb. 23, 2021 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) ("Inspire"), a medical technology company focused on the development and commercialization of innovative and min...

2 months ago - GlobeNewsWire

MINNEAPOLIS, Jan. 20, 2021 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and min...

3 months ago - GlobeNewsWire

MINNEAPOLIS, Jan. 19, 2021 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and min...

3 months ago - GlobeNewsWire

Small-caps Outperform As Breakouts Continue; Inspire Medical, Qualcomm, And Yatsen In Focus

YouTube video

Small-caps take their turn to shine as breakouts continue in Inspire Medical, Qualcomm, and Yatsen. Investor's Business Daily has been helping people invest smarter results by providing exclusive stock ...

Other stocks mentioned: QCOM, YSG
3 months ago - Investors Business Daily

The indices are now remarkably up since the start of the year after where they were in March. The Nasdaq has soared over 43% year to date led by “stay-at-home” high flying tech names.

Other stocks mentioned: MAXR, RDFN, WORK, Z, ZG
4 months ago - Forbes

MINNEAPOLIS, Dec. 22, 2020 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and min...

4 months ago - GlobeNewsWire

During its debut, Tesla fell more than 4%. Meanwhile, the E.U.

Other stocks mentioned: LPSN, SPCE, TENB, WTER
4 months ago - Forbes

Although major indices ended last week at record highs despite a disappointing November jobs report, the Dow and S&P came back down to earth today and slipped. The deep learning algorithms at Q.ai have ...

Other stocks mentioned: CVNA, HASI, PLUG
5 months ago - Forbes

As COVID surges to unprecedented levels with additional shutdown measures taking place, markets dropped after yesterday's surge. Using our deep learning algorithms, our AI has crunched the data to give ...

Other stocks mentioned: CVNA, HASI, PING, Z, ZG
5 months ago - Forbes

MINNEAPOLIS, Nov. 18, 2020 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and min...

5 months ago - GlobeNewsWire

MINNEAPOLIS, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and min...

5 months ago - GlobeNewsWire

Inspire Medical Systems, Inc. (INSP) CEO Tim Herbert on Q3 2020 Results - Earnings Call Transcript

6 months ago - Seeking Alpha

Inspire (INSP) delivered earnings and revenue surprises of 45.07% and 59.33%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

6 months ago - Zacks Investment Research

Shares of Inspire Medical Systems (NYSE:INSP) rose 9.53% in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share were down 14.71% over the past year to ($0.39...

6 months ago - Benzinga

MINNEAPOLIS, Nov. 02, 2020 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) ("Inspire"), a medical technology company focused on the development and commercialization of innovative and min...

6 months ago - GlobeNewsWire

Several medical product stocks have come up with bullish earnings reports so far this reporting cycle. Let's see how STE, HSIC, PACB, INSP are poised ahead of their announcements.

Other stocks mentioned: HSIC, PACB, STE
6 months ago - Zacks Investment Research

MINNEAPOLIS, Oct. 27, 2020 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and min...

6 months ago - GlobeNewsWire

Inspire (INSP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

6 months ago - Zacks Investment Research

MINNEAPOLIS, Sept. 24, 2020 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and ...

7 months ago - GlobeNewsWire

MINNEAPOLIS, Sept. 02, 2020 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and ...

8 months ago - GlobeNewsWire

MINNEAPOLIS, Sept. 01, 2020 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) ("Inspire”), a medical technology company focused on the development and commercialization of innovative and ...

8 months ago - GlobeNewsWire

MINNEAPOLIS, Aug. 17, 2020 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) ("Inspire"), a medical technology company focused on the development and commercialization of innovative and m...

8 months ago - GlobeNewsWire

MINNEAPOLIS, Aug. 12, 2020 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) ("Inspire”), a medical technology company focused on the development and commercialization of innovative and m...

8 months ago - GlobeNewsWire

Inspire Medical Systems, Inc. (INSP) CEO Tim Herbert on Q2 2020 Results - Earnings Call Transcript

9 months ago - Seeking Alpha

Inspire (INSP) delivered earnings and revenue surprises of 18.52% and 39.71%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

9 months ago - Zacks Investment Research

Shares of Inspire Medical Systems (NYSE:INSP) were flat in after-market trading after the company reported Q2 results.

9 months ago - Benzinga

MINNEAPOLIS, Aug. 04, 2020 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) ("Inspire"), a medical technology company focused on the development and commercialization of innovative and m...

9 months ago - GlobeNewsWire

Inspire (INSP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

9 months ago - Zacks Investment Research

MINNEAPOLIS, July 09, 2020 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and m...

10 months ago - GlobeNewsWire

MINNEAPOLIS, June 16, 2020 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) ("Inspire"), a medical technology company focused on the development and commercialization of innovative and m...

10 months ago - GlobeNewsWire

MINNEAPOLIS, June 08, 2020 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and m...

11 months ago - GlobeNewsWire

MINNEAPOLIS, June 03, 2020 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) ("Inspire"), a medical technology company focused on the development and commercialization of innovative and m...

11 months ago - GlobeNewsWire

MINNEAPOLIS, May 11, 2020 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) ("Inspire"), a medical technology company focused on the development and commercialization of innovative and mi...

11 months ago - GlobeNewsWire

Inspire Medical Systems' (INSP) CEO Tim Herbert on Q1 2020 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Inspire (INSP) delivered earnings and revenue surprises of -17.54% and 0.03%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

1 year ago - Zacks Investment Research

Inspire Medical (INSP) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

1 year ago - Zacks Investment Research

Inspire (INSP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 year ago - Zacks Investment Research

MINNEAPOLIS, April 21, 2020 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and ...

1 year ago - GlobeNewsWire

MINNEAPOLIS, April 16, 2020 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE:  INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and...

1 year ago - GlobeNewsWire

MINNEAPOLIS, April 13, 2020 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and ...

1 year ago - GlobeNewsWire

MINNEAPOLIS, April 13, 2020 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and ...

1 year ago - GlobeNewsWire

About INSP

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and Europe. It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. The company also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. Inspire Medical... [Read more...]

Industry
Medical Devices
IPO Date
May 3, 2018
CEO
Timothy Herbert
Employees
341
Stock Exchange
NYSE
Ticker Symbol
INSP
Full Company Profile

Financial Performance

In 2020, INSP's revenue was $115.38 million, an increase of 40.62% compared to the previous year's $82.05 million. Losses were -$57.20 million, 72.1% more than in 2019.

Financial Statements

Analyst Forecasts

According to 13 analysts, the average rating for INSP stock is "Buy." The 12-month stock price forecast is 253.60, which is an increase of 30.32% from the latest price.

Price Target
$253.60
(30.32% upside)
Analyst Consensus: Buy